April 19, 2021

The FDA Should Embrace Remote and Automated Drug Inspection Technology

Patrick McLaughlin

Senior Research Fellow

Tyler Richards

Research Coordinator

The FDA's committment to on-site inspections is causing the U.S. to fall behind. Read more at STAT.